nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
|
Jin, Yujing |
|
2017 |
8 |
3 |
p. 611-621 |
artikel |
2 |
A Practical Review of C-Peptide Testing in Diabetes
|
Leighton, Emma |
|
2017 |
8 |
3 |
p. 475-487 |
artikel |
3 |
A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach
|
Christiansen, Sverre Christian |
|
2017 |
8 |
3 |
p. 489-506 |
artikel |
4 |
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials
|
Sjöstrand, Mikaela |
|
2017 |
8 |
3 |
p. 587-599 |
artikel |
5 |
Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus® Insulin Glargine
|
Ilag, Liza L. |
|
2017 |
8 |
3 |
p. 545-554 |
artikel |
6 |
Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines
|
Strollo, Felice |
|
2017 |
8 |
3 |
p. 507-511 |
artikel |
7 |
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK
|
Vega-Hernandez, Gabriela |
|
2017 |
8 |
3 |
p. 513-530 |
artikel |
8 |
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program
|
Khunti, Kamlesh |
|
2017 |
8 |
3 |
p. 673-682 |
artikel |
9 |
Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
|
Jin, Yujing |
|
2017 |
8 |
3 |
p. 623-624 |
artikel |
10 |
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
|
Zhou, Zhou |
|
2017 |
8 |
3 |
p. 555-571 |
artikel |
11 |
IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting
|
Hunt, Barnaby |
|
2017 |
8 |
3 |
p. 531-544 |
artikel |
12 |
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional
|
Kalra, Sanjay |
|
2017 |
8 |
3 |
p. 659-672 |
artikel |
13 |
Indian Injection Technique Study: Population Characteristics and Injection Practices
|
Kalra, Sanjay |
|
2017 |
8 |
3 |
p. 637-657 |
artikel |
14 |
Resistance Training for Glycemic Control, Muscular Strength, and Lean Body Mass in Old Type 2 Diabetic Patients: A Meta-Analysis
|
Lee, JungHoon |
|
2017 |
8 |
3 |
p. 459-473 |
artikel |
15 |
Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
|
Harreiter, Jürgen |
|
2017 |
8 |
3 |
p. 683-692 |
artikel |
16 |
The Impact of Frequency and Tone of Parent–Youth Communication on Type 1 Diabetes Management
|
DeBoer, Mark D. |
|
2017 |
8 |
3 |
p. 625-636 |
artikel |
17 |
The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis
|
Mita, Tomoya |
|
2017 |
8 |
3 |
p. 693-704 |
artikel |
18 |
The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
|
Kim, So Ra |
|
2017 |
8 |
3 |
p. 601-609 |
artikel |
19 |
Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
|
Haak, Thomas |
|
2017 |
8 |
3 |
p. 573-586 |
artikel |